US$ 28.86
glp-1 agonists brands America's Poison Centers Evolution of GLP‐1 Receptor Agonists
Description
Cureus 15, e38263

Oral GLP-1 options can greatly improve patient compliance and expand the total addressable market

(2023) 5:e313

The medications that started as a treatment for diabetes, regulating patients insulin and blood sugar with a weekly injection, have evolved into what some are calling wonder drugs

Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes

excess or altered GIP signalling may contribute to obesity
